Vertex Pharmaceuticals, Inc. (VRTX)

457.45 -6.41 (-1.38%) USD  |  NASDAQ  |  Jan 12, 12:32
More

Vertex Pharmaceuticals Change in Other Current Liabilities (Quarterly)

Change in Other Current Liabilities (Quarterly) Chart

View Change in Other Current Liabilities (Quarterly) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Other Current Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Other Current Liabilities Definition

View Change in Other Current Liabilities Definition
Start Trial

The increase or decrease in other current liabilities from one period to the next.

Read full definition.

Change in Other Current Liabilities (Quarterly) Range, Past 5 Years

View Change in Other Current Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Other Current Liabilities (Quarterly) Benchmarks

View Change in Other Current Liabilities (Quarterly) Benchmarks
Start Trial
Pfizer Inc. --
Amgen, Inc. Upgrade
Eli Lilly & Co. --
Merck & Co., Inc. --
Regeneron Pharmaceuticals, Inc. --